{"id":"W2010283620","doi":"10.1007/s10495-010-0545-1","title":"XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML","year":2010,"lang":"en","type":"article","venue":"APOPTOSIS","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"National Cancer Institute; National Institutes of Health","keywords":"XIAP; Apoptosis; Inhibitor of apoptosis; Cytarabine; CD34; Cancer research; Medicine; Gene knockdown; Myeloid leukemia; Stem cell; Pharmacology; Biology; Caspase; Programmed cell death; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001795626,0.0002492136,0.0003151496,0.0001923786,0.00005806622,0.00002643008,0.0001497117,0.0002294044,0.00003494923],"category_scores_gemma":[0.00002884179,0.0002110136,0.00004550532,0.0001926868,0.0000731099,0.00002159971,0.0001228926,0.0002256703,0.000001668487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001009741,"about_ca_system_score_gemma":0.00004015559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002148922,"about_ca_topic_score_gemma":0.0003336873,"domain_scores_codex":[0.9985165,0.00009607321,0.0004104929,0.0005013106,0.0002058432,0.0002698099],"domain_scores_gemma":[0.9992312,0.00001968505,0.0002069786,0.0003671777,0.00008590986,0.00008903306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004699077,0.002670049,0.03609299,0.00003038688,0.00005448106,5.540658e-7,0.000523189,0.00003495592,0.9563582,0.00001088859,0.00003583539,0.003718564],"study_design_scores_gemma":[0.005845002,0.002043125,0.08899492,0.00003236289,0.00004270013,3.82191e-7,0.0003718715,0.00003086126,0.9019386,0.00002408055,0.0003812379,0.0002948128],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989398,0.00003877702,0.00003019028,0.000014616,0.00017999,0.0006489508,0.0000376727,0.000009391621,0.0001006284],"genre_scores_gemma":[0.9987362,0.0001057933,0.0008351064,0.00001820411,0.00004266601,0.00003423425,0.0001259436,0.00003475998,0.00006709946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05441955,"threshold_uncertainty_score":0.8604885,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005901417747177447,"score_gpt":0.2254187258450827,"score_spread":0.2195173080979053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}